Plus, more shopper-loved formulas ...
Key Points Interested in Aura Biosciences, Inc.? Here are five stocks we like better. Aura Biosciences says its lead drug bel ...
While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...
While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...
With its lead candidate in a phase 3 trial for a rare eye cancer, Aura Biosciences is looking to expand the drug into a more common disease: bladder cancer. In a phase 1 trial in patients with ...
No treatment-related serious adverse events were reported. Ocular treatment-related AEs were mild and resolved without sequelae. The safety profile of bel-sar was highly favorable in all participants ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results